Literature DB >> 14973326

Enhancement of potency and efficacy of NADA by PKC-mediated phosphorylation of vanilloid receptor.

Louis S Premkumar1, Zhan-Heng Qi, Jeremy Van Buren, Manish Raisinghani.   

Abstract

The search for an endogenous ligand for the vanilloid receptor (VR or TRPV1) has led to the identification of N-arachidonyl dopamine (NADA). This study investigates the role of protein kinase C (PKC)-mediated phosphorylation on NADA-induced membrane currents in Xenopus oocytes heterologously expressing TRPV1 and in dorsal root ganglion (DRG) neurons. In basal state, current induced by 10 microM NADA is 5-10% of the current induced by 1 microM capsaicin or protons at pH 5. However, PKC activator, phorbol 12,13-dibutyrate (PDBu) strongly potentiated ( approximately 15-fold) the NADA-induced current. Repeated application of NADA at short intervals potentiated its own response approximately fivefold in a PKC-dependent manner. PKC inhibitor, bisindolylmaleimide (BIM, 500 nM), a mutant TRPV1 (S800A/S502A), and maximal activation of PKC abolished the potentiation induced by repeated application of NADA. As a further confirmation that NADA could stimulate PKC, pretreatment with NADA potentiated the response of protons at pH 5 (approximately 20 fold), which was dramatically reduced in the mutant TRPV1. In DRG neurons, capsaicin (100 nM) induced a approximately 15 mV depolarization and initiated a train of action potentials compared with 1 microM NADA that produced a approximately 5 mV response. Pretreatment with PDBu induced significantly larger depolarization and potentiated NADA-induced current. Furthermore, exposure of NADA to the intracellular surface of the membrane-induced larger currents suggesting inaccessibility to the intracellular binding site might contribute to its weaker action. These results indicate that NADA is a potent agonist of VR when the receptor is in the PKC-mediated phosphorylation state.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14973326     DOI: 10.1152/jn.00745.2003

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  27 in total

Review 1.  N-acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets.

Authors:  Mark Connor; Chris W Vaughan; Robert J Vandenberg
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Mice lacking functional TRPV1 are protected from pressure overload cardiac hypertrophy.

Authors:  Cadie L Buckley; Alexander J Stokes
Journal:  Channels (Austin)       Date:  2011-07-01       Impact factor: 2.581

Review 3.  TRPV1: on the road to pain relief.

Authors:  Andrés Jara-Oseguera; Sidney A Simon; Tamara Rosenbaum
Journal:  Curr Mol Pharmacol       Date:  2008-11       Impact factor: 3.339

4.  Altered pharmacology of native rodent spinal cord TRPV1 after phosphorylation.

Authors:  A J Mogg; C E J Mill; E A Folly; R E Beattie; M J Blanco; J P Beck; L M Broad
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

5.  Presynaptic inhibition of transient receptor potential vanilloid type 1 (TRPV1) receptors by noradrenaline in nociceptive neurons.

Authors:  Saikat Chakraborty; Vincent Elvezio; Martin Kaczocha; Mario Rebecchi; Michelino Puopolo
Journal:  J Physiol       Date:  2017-02-22       Impact factor: 5.182

Review 6.  The expanding field of cannabimimetic and related lipid mediators.

Authors:  Heather B Bradshaw; J Michael Walker
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

7.  Calcium-dependent and independent mechanisms of capsaicin receptor (TRPV1)-mediated cytokine production and cell death in human bronchial epithelial cells.

Authors:  Christopher A Reilly; Mark E Johansen; Diane L Lanza; Jeewoo Lee; Ju-Ok Lim; Garold S Yost
Journal:  J Biochem Mol Toxicol       Date:  2005       Impact factor: 3.642

8.  Properties of the inner pore region of TRPV1 channels revealed by block with quaternary ammoniums.

Authors:  Andrés Jara-Oseguera; Itzel Llorente; Tamara Rosenbaum; León D Islas
Journal:  J Gen Physiol       Date:  2008-11       Impact factor: 4.086

9.  N-oleoyldopamine, a novel endogenous capsaicin-like lipid, protects the heart against ischemia-reperfusion injury via activation of TRPV1.

Authors:  Beihua Zhong; Donna H Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

Review 10.  TRP channels and analgesia.

Authors:  Louis S Premkumar; Mruvil Abooj
Journal:  Life Sci       Date:  2012-08-14       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.